Skip to content
healthcare.dev
Get a free key

Tracleer

NDC 66215-232, bosentan, tablet, for suspension, from Actelion Pharmaceuticals US, Inc..

Product NDC
66215-232
Status
Listed
Labeler
Actelion Pharmaceuticals US, Inc.
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA209279
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66215-232 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BOSENTAN32 mg/1

Pharmacologic classes

Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Endothelin Receptor Antagonist [EPC]; Endothelin Receptor Antagonists [MoA]

Package NDCNDC-11Package
66215-232-56662150232564 BLISTER PACK in 1 CARTON (66215-232-56) / 14 TABLET, FOR SUSPENSION in 1 BLISTER PACK (66215-232-14)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/749e42fb-2fe0-45dd-9268-b43bb3f4081c

Use it

Look up 66215-232 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66215-232 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66215-232. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.